BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6302318)

  • 1. Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus.
    Edson CM; Thorley-Lawson DA
    J Virol; 1983 May; 46(2):547-56. PubMed ID: 6302318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus membrane antigens: characterization, distribution, and strain differences.
    Edson CM; Thorley-Lawson DA
    J Virol; 1981 Jul; 39(1):172-84. PubMed ID: 6268807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2.
    Balachandran N; Hutt-Fletcher LM
    J Virol; 1985 Jun; 54(3):825-32. PubMed ID: 2987534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
    Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
    Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2.
    Cohen GH; Long D; Matthews JT; May M; Eisenberg R
    J Virol; 1983 Jun; 46(3):679-89. PubMed ID: 6304338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties.
    Montalvo EA; Parmley RT; Grose C
    J Virol; 1985 Mar; 53(3):761-70. PubMed ID: 2983087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of an unglycosylated envelope glycoprotein of Rous sarcoma virus in the presence of tunicamycin.
    Diggelmann H
    J Virol; 1979 Jun; 30(3):799-804. PubMed ID: 90167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycoproteins of murine leukemia viruses. III. Glycosylation of env precursor glycoproteins.
    Kemp MC; Famulari NG; Compans RW
    J Virol; 1981 Aug; 39(2):463-70. PubMed ID: 6268835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110.
    Gong M; Kieff E
    J Virol; 1990 Apr; 64(4):1507-16. PubMed ID: 2157039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypeptides of Mason-Pfizer monkey virus. II. Synthesis and processing of the env gene products.
    Bradac J; Hunter E
    Virology; 1986 Apr; 150(2):491-502. PubMed ID: 3083581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells.
    Ericson BL; Graham DY; Mason BB; Estes MK
    J Virol; 1982 Jun; 42(3):825-39. PubMed ID: 6284998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precursor polypeptides to structural proteins of visna virus.
    Vigne R; Filippi P; Quérat G; Sauze N; Vitu C; Russo P; Delori P
    J Virol; 1982 Jun; 42(3):1046-56. PubMed ID: 6178845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational processing and activation of insulin and EGF proreceptors.
    Lane MD; Ronnett G; Slieker LJ; Kohanski RA; Olson TL
    Biochimie; 1985; 67(10-11):1069-80. PubMed ID: 3000457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.
    Sithole I; Lee LF; Velicer LF
    J Virol; 1988 Nov; 62(11):4270-9. PubMed ID: 2845139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus.
    Serafini-Cessi F; Malagolini N; Nanni M; Dall'Olio F; Campadelli-Fiume G; Tanner J; Kieff E
    Virology; 1989 May; 170(1):1-10. PubMed ID: 2541535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.
    Britt WJ; Vugler LG
    J Virol; 1989 Jan; 63(1):403-10. PubMed ID: 2535741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel intermediate in processing of murine leukemia virus envelope glycoproteins. Proteolytic cleavage in the late Golgi region.
    Bedgood RM; Stallcup MR
    J Biol Chem; 1992 Apr; 267(10):7060-5. PubMed ID: 1313032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein.
    Yaswen LR; Stephens EB; Davenport LC; Hutt-Fletcher LM
    Virology; 1993 Aug; 195(2):387-96. PubMed ID: 8393232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis.
    Lokeshwar VB; Bourguignon LY
    J Biol Chem; 1991 Sep; 266(27):17983-9. PubMed ID: 1833390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation pathways of two major Epstein-Barr virus membrane antigens.
    Strnad BC; Adams MR; Rabin H
    Virology; 1983 May; 127(1):168-76. PubMed ID: 6305014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.